Moderators:
Search This Board: 
Created: 10/14/2010 01:11:47 PM - Followers: 6 - Board type: Free - Posts Today: 0
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#114
98.6% Institutional ownership. Wheat123 04/15/2022 08:27:39 AM
#113
Big Momma thinks more to come this week. Big Momma 08/22/2021 02:57:35 PM
#112
"We eagerly anticipate results from additional Phase 3 dinogreeves 08/18/2021 11:27:40 PM
#111
ok bigrun 08/18/2021 11:24:32 PM
#110
YW. Just watch it premarket and then dinogreeves 08/18/2021 11:03:38 PM
#109
Thx man bigrun 08/18/2021 10:57:37 PM
#108
thx bigrun 08/18/2021 10:55:48 PM
#107
Read the press release they issued today, most dinogreeves 08/18/2021 10:51:21 PM
#106
As of July 31, 13.87% short interest. crudeoil24 08/18/2021 10:50:09 PM
#105
Coherus and Junshi Biosciences Announce Positive Interim Results crudeoil24 08/18/2021 10:43:33 PM
#104
What happened here after trading hours? What is bigrun 08/18/2021 10:12:42 PM
#103
Huge move for the rest of this week dinogreeves 08/18/2021 09:47:22 PM
#102
You got to love the institutions on this ticker dinogreeves 08/18/2021 09:00:02 PM
#101
500 million in revenues, only way is up. dinogreeves 08/18/2021 08:57:47 PM
#100
Big explosion after hours here. Big Momma 08/18/2021 07:42:21 PM
#99
This is the holy grail guys, this market dinogreeves 08/18/2021 07:28:04 PM
#98
CHRS is the next big runner tomorrow, by dinogreeves 08/18/2021 07:11:23 PM
#97 Board is dead, eh? Dr Speculator Ninja 06/07/2020 11:56:50 PM
#95 CHRS had its 4Q17 earnings release and CC DewDiligence 03/09/2018 01:20:08 PM
#94 Strong move up! CHRS crudeoil24 03/09/2018 12:59:27 PM
#92 Transcript of CHRS 3Q17 CC: DewDiligence 11/07/2017 11:35:53 AM
#91 CHRS -7% on suspension of Humira-FoB development: #msg-135992347. DewDiligence 11/07/2017 10:36:21 AM
#90 CHRS 3Q17 results: DewDiligence 11/06/2017 04:09:38 PM
#89 Musings on ABBV-AMGN Humira settlement: DewDiligence 09/28/2017 05:33:22 PM
#88 $CHRS Coherus Biosciences, Inc. https://www.barchart.com/story/stocks/qu BottomBounce 09/27/2017 10:26:41 PM
#87 USPTO denies CHRS’ IPR on ABBV’s ‘619 patent: #msg-134452711. DewDiligence 09/07/2017 03:00:18 PM
#86 CHRS raises $75M in private placement: #msg-133994513. DewDiligence 08/21/2017 09:57:56 AM
#85 CHRS 2Q17 CC transcript: DewDiligence 08/10/2017 11:17:07 AM
#84 CHRS now hopes to submit Humira FoB applications DewDiligence 08/07/2017 06:06:16 PM
#83 …what is a success rate of approval of DewDiligence 07/12/2017 02:42:43 PM
#82 Thanks Dew for pointing mistake. tika1 07/10/2017 02:11:35 PM
#81 They're not generic drugs. They're follow-on biologics. DewDiligence 07/10/2017 12:08:23 PM
#80 Coherus BioSciences is at 52 weeks low. tika1 07/10/2017 11:53:17 AM
#79 https://seekingalpha.com/article/4085829-coherus-biosciences-prospects-arsenal Inoviorulez 07/05/2017 05:19:56 PM
#78 30% workforce reduction: #msg-132546687. DewDiligence 06/27/2017 04:22:32 PM
#77 CHRS BLA for Humira FoB delayed to 1H18 DewDiligence 06/26/2017 04:27:37 PM
#76 $CHRS based on projections that CHS-1701 can achieve Mr_Popeye 06/14/2017 12:44:00 AM
#75 CHRS -30% on CRL for Neulasta FoB: DewDiligence 06/12/2017 10:05:24 AM
#74 Transcript of 1Q17 CC: DewDiligence 05/15/2017 10:41:33 AM
#73 CHRS 1Q17 PR: DewDiligence 05/15/2017 10:40:59 AM
#72 Musings on ABBV's US IP: #msg-118781959. DewDiligence 05/07/2017 08:12:34 PM
#71 CHRS’s Jun 2016 PR on ABBV’s ‘680 and DewDiligence 05/07/2017 08:11:37 PM
#70 CHRS’s May 2016 USPTO win vs ABBV on DewDiligence 05/07/2017 08:11:02 PM
#69 Brief notes on ABBV's Humira-dosing patents: #msg-131147449. DewDiligence 05/07/2017 08:08:36 PM
#68 CHRS had $124.9M cash at 12/31/16—a burn of DewDiligence 03/13/2017 04:36:37 PM
#67 USPTO rules for ABBV—against CHRS—on Humira ‘166 patent: DewDiligence 11/07/2016 12:36:16 PM
#66 CHRS bullish 24.31 stocktrademan 07/26/2016 09:55:32 AM
#65 14% drop today seems about right: #msg-119053489. DewDiligence 12/09/2015 07:58:43 PM
#64 CHRS has run into some trouble showing bioequivalence DewDiligence 12/08/2015 05:09:33 PM
#63 220K @ $25 AH looks like a fund; rebalancing. RealGenius 10/27/2015 05:47:25 PM
Post Subject